Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells

Atherosclerosis
Constanze MeyePeter Gross

Abstract

One aspect of homocysteine (Hcy) action is the impairment of endothelial cell function due to an impairment of endothelial nitric oxide (NO) production. The activity of the endothelial isoform of NO synthase (eNOS) is regulated by its interaction with caveolin-1 (Cav-1). The aim of this study was to determine whether Hcy may alter the levels of Cav-1 and eNOS in endothelial caveolae. We isolated caveolae-enriched membrane fractions from Hcy-treated human coronary artery endothelial cells. We found that treatment with 500 microM Hcy for 6h significantly reduced the levels of Cav-1 and eNOS in caveolae compared to untreated control by 47+/-7% and by 38+/-14%, respectively. Similarly, long-term incubation (96h) of HCAEC with 100 microM Hcy led to a comparable effect. The decreased Cav-1 abundance in endothelial caveolae in response to Hcy resulted from a decrease in Cav-1 expression at the transcriptional level. The reduced levels of eNOS in caveolae were caused by a translocation of eNOS from the caveolar fractions to noncaveolar fractions. The effects of Hcy were associated with an impairment of stimulated release of NO. These results suggest that Hcy induced impairment of NO production through a modulation of Cav-1 expression a...Continue Reading

References

Apr 25, 1991·The New England Journal of Medicine·R ClarkeI Graham
Oct 4, 1995·JAMA : the Journal of the American Medical Association·C J BousheyA G Motulsky
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·A M FraR G Parton
Mar 15, 1996·The Journal of Biological Chemistry·P W ShaulT Michel
Jul 1, 1996·The Journal of Clinical Investigation·J Loscalzo
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·C J FieldingP E Fielding
Jun 20, 1997·The Journal of Biological Chemistry·J B MichelT Michel
Jul 4, 1997·The Journal of Biological Chemistry·G R UpchurchJ Loscalzo
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·A BistC J Fielding
Aug 17, 1999·Current Opinion in Cell Biology·T V Kurzchalia, R G Parton
Jan 17, 2002·The Journal of Surgical Research·Changyi ChenDian-sheng Zhong
Feb 22, 2003·Journal of the American Society of Nephrology : JASN·Patricia A FischerLucas D Masnatta
May 7, 2004·European Journal of Biochemistry·Unn OrtegrenPeter Strålfors

❮ Previous
Next ❯

Citations

Aug 27, 2011·Antioxidants & Redox Signaling·Zhi-Gang SheDe-Pei Liu
Nov 26, 2008·European Heart Journal·Charalambos AntoniadesChristodoulos Stefanadis
Aug 12, 2008·BMC Pharmacology·Rajeshkumar U KoladiyaBhupesh K Sharma
Apr 15, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chantal SéguinWilliam C Aird
Aug 21, 2007·Thrombosis Research·Suh-Hang Hank JuoChin-San Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.